AAA

Affinity Asset Advisors Portfolio holdings

AUM $676M
This Quarter Return
+16.34%
1 Year Return
+29.75%
3 Year Return
+452.89%
5 Year Return
–
10 Year Return
–
AUM
$645M
AUM Growth
+$645M
Cap. Flow
-$54.3M
Cap. Flow %
-8.43%
Top 10 Hldgs %
44.28%
Holding
108
New
9
Increased
21
Reduced
28
Closed
17

Top Buys

1
NUVL icon
Nuvalent
NUVL
$14.1M
2
ALKS icon
Alkermes
ALKS
$9.8M
3
VRDN icon
Viridian Therapeutics
VRDN
$8.53M
4
ORKA
Oruka Therapeutics, Inc. Common Stock
ORKA
$8.43M
5
WVE icon
Wave Life Sciences
WVE
$8.41M

Top Sells

1
CERE
Cerevel Therapeutics Holdings, Inc. Common Stock
CERE
$20.4M
2
ONC
BeOne Medicines Ltd. American Depositary Shares
ONC
$16.8M
3
CLDX icon
Celldex Therapeutics
CLDX
$11.9M
4
APGE icon
Apogee Therapeutics
APGE
$10.1M
5
MORF
Morphic Holding, Inc. Common Stock
MORF
$8.54M

Sector Composition

1 Healthcare 92.7%
2 Financials 0.54%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
MORF
76
DELISTED
Morphic Holding, Inc. Common Stock
MORF
– –
-250,573
Closed -$8.54M
SYRS
77
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
– –
0
– –
ZYME icon
78
Zymeworks
ZYME
$1.07B
– –
-191,127
Closed -$1.63M
XBI icon
79
SPDR S&P Biotech ETF
XBI
$5.29B
– –
-37,550
Closed -$3.48M
VIR icon
80
Vir Biotechnology
VIR
$765M
– –
-200,000
Closed -$1.78M
TWST icon
81
Twist Bioscience
TWST
$1.57B
– –
0
– –
TNGX icon
82
Tango Therapeutics
TNGX
$745M
– –
-150,274
Closed -$1.29M
SPY icon
83
SPDR S&P 500 ETF Trust
SPY
$656B
– –
0
– –
SPRY icon
84
ARS Pharmaceuticals
SPRY
$1.08B
– –
0
– –
SMMT icon
85
Summit Therapeutics
SMMT
$17.5B
– –
0
– –
SAVA icon
86
Cassava Sciences
SAVA
$107M
– –
0
– –
SANA icon
87
Sana Biotechnology
SANA
$759M
– –
0
– –
RAPT icon
88
RAPT Therapeutics
RAPT
$187M
– –
-75,000
Closed -$229K
PASG icon
89
Passage Bio
PASG
$22.7M
– –
-264,266
Closed -$210K
OLMA icon
90
Olema Pharmaceuticals
OLMA
$432M
– –
-275,000
Closed -$2.98M
NVAX icon
91
Novavax
NVAX
$1.2B
– –
0
– –
MRSN icon
92
Mersana Therapeutics
MRSN
$34.8M
– –
-767,000
Closed -$1.54M
IOVA icon
93
Iovance Biotherapeutics
IOVA
$800M
– –
-100
Closed -$802
HLVX icon
94
HilleVax
HLVX
$105M
– –
-265,859
Closed -$3.84M
GALT icon
95
Galectin Therapeutics
GALT
$288M
– –
0
– –
FULC icon
96
Fulcrum Therapeutics
FULC
$353M
– –
0
– –
ELEV
97
DELISTED
Elevation Oncology
ELEV
– –
-1,468,825
Closed -$3.97M
DYN icon
98
Dyne Therapeutics
DYN
$1.92B
– –
-100,000
Closed -$3.53M
BDTX icon
99
Black Diamond Therapeutics
BDTX
$164M
– –
-650,000
Closed -$3.03M
ANAB icon
100
AnaptysBio
ANAB
$630M
– –
0
– –
1 2 3
4
5